Neuren Pharmaceuticals Profile

USD 0.11  4.68%

Neuren Pharmaceuticals Summary

Neuren Pharmaceuticals Limited (NURPF) is traded on OTC Market in USA. It is located in 435 Williamstown Road and employs 10 people. The company currently falls under 'Small-Cap' category with current market capitalization of 225.78 M. Neuren Pharmaceuticals Limited has 92.1 M outstanding shares. NEUREN PHARMACEUT has accumulated about 3.7 M in cash with (4.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Check Neuren Pharmaceuticals Probability Of Bankruptcy

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Orleans Capital Management CorpCommon Shares10 K1000
Orleans Capital Management CorpCommon Shares10 K1000
View Neuren Pharmaceuticals Diagnostics

Neuren Pharmaceuticals Risk Profiles

Key Fundamentals

Neuren Pharmaceuticals Against Markets

Current Ratings

Neuren Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 94% 
Equity ratings for Neuren Pharmaceuticals Limited are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Neuren Pharmaceuticals Limited, a biopharmaceutical company, focuses on the development of therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Neuren Pharmaceuticals Limited was incorporated in 1993 and is based in Port Melbourne, Australia. Neuren Pharmaceuticals is traded on OTC Market in USA. more
NameNeuren Pharmaceuticals Limited
CEO, Managing DirectorLarry GlassView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address435 Williamstown Road
ExchangeOTC Market
Contact Number61 3 9092 0480
CurrencyUSD - US Dollar

Diversify with Neuren Pharmaceuticals Limited

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Neuren Pharmaceuticals Limited to your portfolio


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Neuren Pharmaceuticals Corporate Executives
Jon Pilcher CFO, Company Secretary
James Shaw COO